PRECIGEN, INC. Share Price
PRECIGEN, INC. (PGEN) had Share Price of $1.42 per share as of 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2025-08-12
- 2025-06-30: Share Price $1.42.
- 2025-03-31: Share Price $1.49.
- 2015-08-31: Share Price $41.00.
- 2015-01-31: Share Price $27.00.
| Period end | Share Price |
|---|---|
| 2025-06-30 | $1.42 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.49 10-Q · filed 2025-05-14 |
| 2015-08-31 | $41.00 10-Q · filed 2015-11-09 |
| 2015-01-31 | $27.00 10-Q · filed 2015-11-09 |
| 2014-03-31 | $25.72 10-Q · filed 2015-11-09 |
| 2014-03-26 | $25.72 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |